John Haanen, MD, PhD, of the Netherlands Cancer Institute in Amsterdam, and colleagues, in collaboration with Ugur Sahin’s team at BioNTech in Germany, tested a novel type of CAR-T therapy that ...

Meanwhile, across the country, members of the Los Angeles Pink Dragons, trained in the summer for the annual International Dragon Boat festival in Long Beach, California, held in July, and the 10 th ...

Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...

The global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. One in 5 men and one in 6 women worldwide develop cancer during their lifetime, and one in ...

Akiko Hanai of Kyoto University and her colleagues studied peripheral neuropathy prevention in 40 women receiving paclitaxel for breast cancer. The average age was 56. The women wore Elasto-Gel frozen ...

One month after completion of chemotherapy, fewer people in both the cooling and compression groups had neuropathy in the treated hand compared with the untreated hand. But neuropathy symptoms ...

Galleri, a blood test that aims to detect over 50 cancers, illustrates the promise and popularity of an emerging technology to screen for cancer. Although the blood test is not approved by the Food ...

Squamous cell skin cancer is the second most common cancer in the United States (after basal cell skin cancer), with an estimated 700,000 new cases diagnosed annually, according to the FDA. CSCC is ...

in people previously treated with Nexavar (sorafenib). The approval of Cabometyx for HCC comes soon after the approval of another kinase inhibitor, Lenvima (lenvatinib), last August and the checkpoint ...

The latest study, titled “A global perspective on coal-fired power plants and burden of lung cancer,” published in the journal Environmental Health, looked at data from 13,581 coal-fired plants in 83 ...

Luckily, a vast range of skilled and dedicated patient advocates can provide support to people with cancer and their loved ones. They raise funds and awareness, build programs and communities, share ...

A next-generation armored CAR-T therapy called C-CAR031 led to regression of liver tumors in more than half of patients with advanced hepatocellular carcinoma, rising to 75% for those who received the ...